Business Wire

VA-HILTON

16.11.2023 15:46:31 CET | Business Wire | Press release

Share
Hilton Named No. 1 Best Place to Work in the World

For the first time ever, Hilton has been named the No. 1 World’s Best Workplace by Fortune magazine and Great Place to Work. This recognition – the culmination of eight consecutive appearances on the “World’s Best” list – also marks the first time a hospitality company has achieved the top honor in this best-in-class program.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231115572899/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Hilton)

Since first earning a spot on this list in 2016, Hilton has continued to build its strong culture through an unwavering focus on creating a workplace that is inclusive, offers strong growth opportunities, is driven by purpose, and provides the kind of support that empowers its 460,000 team members around the world to thrive each and every day.

“Around the world at Hilton, our 460,000 team members are united by a common purpose: to fill the earth with the light and warmth of hospitality. That purpose was formed more than a century ago, when Conrad Hilton set out to change the world through travel. He built this company on the noble premise that Hilton could be a force for good in the world, and famously urged us all to think big, act big, and dream big,” said Chris Nassetta, president and CEO, Hilton. “Today’s recognition by Great Place to Work and Fortune is validation that our team members were the people he imagined in his bright vision for the future. It is their dedication, hospitality and passion for the stays they create that has made Hilton the No. 1 best place to work in the world.”

Hilton is dedicated to building an inclusive culture that supports team members at every stage of their personal and professional journey and empowers each of them to bring their true, authentic self to work.

The hospitality company provides best-in-class benefits to both hourly and salaried team members, including expanded parental leave, adoption assistance and exciting travel benefits through its popular Go Hilton team member travel program.

Hilton, along with the Hilton Global Foundation, also announced today that it will launch Hilton Cares – a program that will provide $500,000 in scholarships and financial assistance for both team members and members of the community passionate about building and growing careers in hospitality. Applications will open in early 2024.

Hilton is constantly seeking new ways to increase flexibility at its properties and corporate offices and is committed to providing a value proposition that offers a flexible ecosystem of offerings that allow team members to feel supported.

“At Hilton, we are building a fully human experience at work, where our team members feel like they are seen, they are welcome, and they are part of something greater than themselves,” said Laura Fuentes, chief human resources officer, Hilton. “Today’s recognition reinforces what employees are looking for – a workplace culture that helps them reach their full potential.”

Four Pillars Supporting a Great Place to Work
In building a fully human experience at work, Hilton focuses on a framework of four pillars, including:

Inclusion: Hilton is committed to an equitable and welcoming workforce that represents a broad range of cultures, backgrounds, and viewpoints representative of the guests and communities it serves. Fair360 welcomed Hilton into its Hall of Fame in 2022, following the 2021 No. 1 ranking on the organization’s Top 50 Companies for Diversity list.

Wellness: As part of its Thrive at Hilton platform, Hilton proactively supports team members in caring not only for themselves, but also for those closest to them. In 2022, the company launched its industry-leading Care for All caregiving initiative, a robust platform of tools and resources to support the mental wellness and caregiving needs of team members.

Growth: Hilton prides itself in providing opportunities where team members come for a job but stay for a career. Educational opportunities include complimentary courses through Hilton University, upskilling for people leaders, debt-free education through the company’s partnership with Guild, and Lead@Hilton leadership and development programs.

Purpose: For more than a century, team members have helped fulfill Conrad Hilton’s founding vision to spread the light and warmth of hospitality throughout the world. Even during the challenges of the COVID-19 pandemic, Hilton’s team members never lost sight of that purpose and found ways to use their diverse talents to deliver exceptional guest experiences, to have a positive impact on communities and to help bring moments of joy and kindness to life through travel.

To determine the World’s Best Workplaces each year, Great Place to Work invites companies to take part in a rigorous, data-based model that quantifies the employee experience. The process includes soliciting employee feedback through surveys, collecting data about company culture and workforces and achieving certification status. From there, companies must be identified as outstanding global employers by appearing on at least five Best Workplaces™ Lists in Asia, Europe, Latin America, Africa, North America, or Australia during 2022 or early 2023.

This recognition is a result of positive feedback directly from team members among a workforce spanning 460,000 people across 124 countries and territories. In addition to the World’s Best Workplace honor, earlier this year Hilton was named the Best Workplace for Women in the U.S. and is honored to have been recognized throughout 2023 as the No. 1 Best Workplace in multiple countries, including Argentina, Austria, China, Dominican Republic, France, India, Italy, Peru, Portugal, Switzerland and Uruguay. In total, Hilton has been recognized on more than 450 Great Place to Work lists since 2016. Read more about Great Place to Work’s Methodology here.

For more information on Hilton’s expansive team member benefits, its award-winning workplace culture and the many kinds of jobs available, visit jobs.hilton.com.

# # #

About Hilton
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 22 world-class brands comprising nearly 7,400 properties and more than 1.1 million rooms, in 124 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed more than 3 billion guests in its more than 100-year history, earned a top spot on Fortune's 100 Best Companies to Work For list and been recognized as a global leader on the Dow Jones Sustainability Indices for six consecutive years. Hilton has introduced several industry-leading technology enhancements to improve the guest experience, including Digital Key Share, automated complimentary room upgrades and the ability to book confirmed connecting rooms. Through the award-winning guest loyalty program Hilton Honors, the more than 173 million members who book directly with Hilton can earn Points for hotel stays and experiences money can't buy. With the free Hilton Honors app, guests can book their stay, select their room, check in, unlock their door with a Digital Key and check out, all from their smartphone. Visit stories.hilton.com for more information, and connect with Hilton on Facebook, Twitter, LinkedIn, Instagram and YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231115572899/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye